News Truxima, world's first cancer drug biosimilar approved in Eu... Roche's top seller faces rival four years after patent expiry
News Pfizer's fast-tracked leukaemia candidate could rival CAR-Ts Antibody-drug conjugate with FDA gets six-month review.
News Rare leukaemia drug gets funding for phase 2 trial Investment fund kick-starts phase 2 trial in CMML
News J&J/AbbVie blood cancer drug gets fifth US indication Imbruvica approved in marginal zone lymphoma.
News AbbVie bullish on Humira and near-term pipeline Sales of Humira could peak above $18 billion - CEO
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
